Back to results
US 2023/0416235 A1Published application
Benzamides of pyrazolylamino- pyrimidinyl derivatives, and compositions and methods thereof
AssigneeLynk Pharmaceuticals Co. Ltd.
InventorsZhaokui Wan, Michael Lawrence Vazquez, Xiaodong Li
Life of this patent
Estimating the term…
Abstract
The invention provides a novel class of orally and/or topically available, selective and potent JAK inhibitors as safe and effective therapeutics against various diseases and disorders. The invention also provides pharmaceutical composition of these compounds and methods of their preparation and use thereof.
Claims14
1-92. (canceled)
A compound having the structural formula (I):
- wherein
- X is N or CRX, wherein RX is R′, halogen, CN or OR′;
- each of Z1 and Z2 is independently selected from N and CR′, provided that one of Z1 and Z2 is N and the other is CR′;
- R1 is CH3;
- R2 is a six-membered cyclic aliphatic group comprising a N or O, wherein the aliphatic group is substituted with one or more C1-C3 alkyl groups;
- R3 is R′, halogen or CN;
- R4′ is H;
- R4 is —CHR″-R5, wherein R″ is H or a C1-C6 alkyl and R5 is a CN or CF3;
- and
- R′ is hydrogen or a C1-C3 unsubstituted or substituted alkyl group, or a pharmaceutically acceptable form or an isotope derivative thereof.
7 more elements
Dependencies are inferred from the claim text.